XML 30 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Net Earnings (loss) Per Common Share
The following table sets forth the computation of basic and diluted net earnings (loss) per common share (in thousands, except share and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Numerator:
Net income (loss)$14,978 $(18,083)$(16,422)$(25,664)
Allocation of earnings to participating securities(3,081)— — — 
Numerator for basic net earnings (loss) per share - net income (loss) attributable to common stockholders$11,897 $(18,083)$(16,422)$(25,664)
Effect of participating securities:
Add back allocation of earnings to participating securities3,081 — — — 
Numerator for diluted net earnings (loss) per share - net income (loss) attributable to common stockholders after assumed conversions$14,978 $(18,083)$(16,422)$(25,664)
Denominator:
Denominator for basic net earnings (loss) per share - common shares outstanding70,217,985 49,533,956 69,170,865 48,402,095 
Effect of dilutive securities:
Series X Convertible Preferred Stock, as converted18,184,720 — — — 
Common stock options, RSUs, PRSUs, and ESPP189,863 — — — 
Denominator for diluted net earnings (loss) per share - adjusted weighted average shares outstanding88,592,568 49,533,956 69,170,865 48,402,095 
Basic net earnings (loss) per common share$0.17 $(0.37)$(0.24)$(0.53)
Diluted net earnings (loss) per common share$0.17 $(0.37)$(0.24)$(0.53)
Summary of Outstanding Potentially Dilutive Securities Excluded from Calculation of Diluted Net Earnings (Loss) Per Share
The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net earnings (loss) per share because doing so would be anti-dilutive (in common stock equivalent shares):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Common stock warrants12,517,328 12,517,328 12,517,328 12,517,328 
Series X Convertible Preferred Stock— 10,442,780 18,184,720 10,442,780 
Common stock options, RSUs and PRSUs issued and outstanding10,041,333 10,356,267 10,086,839 10,356,267 
Total22,558,661 33,316,375 40,788,887 33,316,375